Our first products will be flavours and fragrances.
Find out more about our extensive library of patented cytochrome P450 enzymes.
Find out more about Oxford Biotrans and the people behind the business.
10th October 2017 Oxford Biotrans has announced that it has closed £2.1m in new funding. The investment was led by Touchstone Innovations (formerly Imperial Innovations)